KK Therapeutics ApS
CVR number: 40378111
Amagerbrogade 18, 2300 København S
karl.agger@bric.ku.dk
tel: 22832639
Income statement (kDKK)
| 2019 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | -30.00 |
| EBIT | -30.00 |
| Other financial expenses | -2.79 |
| Pre-tax profit | -32.79 |
| Net earnings | -32.79 |
Assets (kDKK)
| 2019 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Short term receivables total | |
| Cash and bank deposits | 23.46 |
| Cash and cash equivalents | 23.46 |
| Balance sheet total (assets) | 23.46 |
Equity and liabilities (kDKK)
| 2019 | |
|---|---|
| Share capital | 50.00 |
| Profit of the financial year | -32.79 |
| Shareholders equity total | 17.21 |
| Non-current liabilities total | |
| Other non-interest bearing current liabilities | 6.25 |
| Current liabilities total | 6.25 |
| Balance sheet total (liabilities) | 23.46 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.